Banco Bilbao Vizcaya Argentaria S.A. Sells 1,374 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Banco Bilbao Vizcaya Argentaria S.A. reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,213 shares of the company's stock after selling 1,374 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in HCA Healthcare were worth $8,772,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Congress Wealth Management LLC DE raised its holdings in HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after acquiring an additional 34 shares during the last quarter. Evergreen Private Wealth LLC grew its holdings in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after buying an additional 35 shares during the period. Mediolanum International Funds Ltd boosted its position in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. raised its stake in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after purchasing an additional 40 shares during the period. Finally, Whittier Trust Co. grew its stake in shares of HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after buying an additional 41 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Guggenheim initiated coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Royal Bank of Canada cut their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research report on Monday. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Barclays lowered their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $381.13.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $1.90 during trading hours on Wednesday, reaching $342.48. The company's stock had a trading volume of 453,876 shares, compared to its average volume of 1,392,451. The stock has a market cap of $84.32 billion, a P/E ratio of 15.59, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company's 50 day simple moving average is $330.44 and its 200 day simple moving average is $331.39. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm's revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the business earned $5.36 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.84%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.